img

Global Short Bowel Syndrome (SBS) Drugs Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application

Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Short Bowel Syndrome (SBS) Drugs Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application

Short bowel syndrome (SBS) is a metabolic disorder occurs when the portion of the small intestine is not functioning or removed through surgery due to digestive illness. SBS is caused by lack of function of the small intestine. This results in malabsorption, diarrhea, steatorrhea, fluid and electrolyte disturbances, and malnutrition.
Short Bowel Syndrome (SBS) Drugs report published by QYResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Short Bowel Syndrome (SBS) Drugs market is projected to reach US$ million in 2034, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2034. Demand from Hospitals and Clinics are the major drivers for the industry.
During 2017, the parental route segment accounted for the major shares and dominated the SBS market. Factors such as the rapid action mechanism of the drug and the prolonged action result contribute to the growth of this market segment in the coming years. In the parental route, the drug is administered intravenously, subcutaneously, intrathecally, or through intramuscular routes and is applied when the oral route of drug administration is ineffective.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Short Bowel Syndrome (SBS) Drugs market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Sale Channel and Regions Listed in the Report



By Company


Merck
Takeda
Emmaus Medical
Ardelyx
Naia Pharmaceuticals
Nutrinia
OxThera
Sancilio Pharmaceuticals
Zealand Pharma
Segment by Type
Glucagon-Like Peptide-2 (GLP-2)
Growth Hormone
Glutamine
Other
Segment by Sale Channel
Hospitals
Clinics
Retail Pharmacies

Segment by Region


North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Short Bowel Syndrome (SBS) Drugs market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Short Bowel Syndrome (SBS) Drugs, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Short Bowel Syndrome (SBS) Drugs industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Short Bowel Syndrome (SBS) Drugs in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Sale Channel, Volume and Revenue analysis of Each Sale Channel in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Short Bowel Syndrome (SBS) Drugs introduction, etc. Short Bowel Syndrome (SBS) Drugs Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13QYResearch’s Conclusions of Short Bowel Syndrome (SBS) Drugs market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by QYResearch.

Table of Content

1 Short Bowel Syndrome (SBS) Drugs Market Overview
1.1 Short Bowel Syndrome (SBS) Drugs Product Overview
1.2 Short Bowel Syndrome (SBS) Drugs Market Segment by Type
1.2.1 Glucagon-Like Peptide-2 (GLP-2)
1.2.2 Growth Hormone
1.2.3 Glutamine
1.2.4 Other
1.3 Global Short Bowel Syndrome (SBS) Drugs Market Size by Type
1.3.1 Global Short Bowel Syndrome (SBS) Drugs Market Size Overview by Type (2018-2034)
1.3.2 Global Short Bowel Syndrome (SBS) Drugs Historic Market Size Review by Type (2018-2024)
1.3.3 Global Short Bowel Syndrome (SBS) Drugs Forecasted Market Size by Type (2024-2034)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Short Bowel Syndrome (SBS) Drugs Sales Breakdown by Type (2018-2024)
1.4.2 Europe Short Bowel Syndrome (SBS) Drugs Sales Breakdown by Type (2018-2024)
1.4.3 Asia-Pacific Short Bowel Syndrome (SBS) Drugs Sales Breakdown by Type (2018-2024)
1.4.4 Latin America Short Bowel Syndrome (SBS) Drugs Sales Breakdown by Type (2018-2024)
1.4.5 Middle East and Africa Short Bowel Syndrome (SBS) Drugs Sales Breakdown by Type (2018-2024)
2 Global Short Bowel Syndrome (SBS) Drugs Market Competition by Company
2.1 Global Top Players by Short Bowel Syndrome (SBS) Drugs Sales (2018-2024)
2.2 Global Top Players by Short Bowel Syndrome (SBS) Drugs Revenue (2018-2024)
2.3 Global Top Players by Short Bowel Syndrome (SBS) Drugs Price (2018-2024)
2.4 Global Top Manufacturers Short Bowel Syndrome (SBS) Drugs Manufacturing Base Distribution, Sales Area, Product Type
2.5 Short Bowel Syndrome (SBS) Drugs Market Competitive Situation and Trends
2.5.1 Short Bowel Syndrome (SBS) Drugs Market Concentration Rate (2018-2024)
2.5.2 Global 5 and 10 Largest Manufacturers by Short Bowel Syndrome (SBS) Drugs Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Short Bowel Syndrome (SBS) Drugs as of 2022)
2.7 Date of Key Manufacturers Enter into Short Bowel Syndrome (SBS) Drugs Market
2.8 Key Manufacturers Short Bowel Syndrome (SBS) Drugs Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Short Bowel Syndrome (SBS) Drugs Status and Outlook by Region
3.1 Global Short Bowel Syndrome (SBS) Drugs Market Size and CAGR by Region: 2018 VS 2022 VS 2034
3.2 Global Short Bowel Syndrome (SBS) Drugs Historic Market Size by Region
3.2.1 Global Short Bowel Syndrome (SBS) Drugs Sales in Volume by Region (2018-2024)
3.2.2 Global Short Bowel Syndrome (SBS) Drugs Sales in Value by Region (2018-2024)
3.2.3 Global Short Bowel Syndrome (SBS) Drugs Sales (Volume & Value) Price and Gross Margin (2018-2024)
3.3 Global Short Bowel Syndrome (SBS) Drugs Forecasted Market Size by Region
3.3.1 Global Short Bowel Syndrome (SBS) Drugs Sales in Volume by Region (2024-2034)
3.3.2 Global Short Bowel Syndrome (SBS) Drugs Sales in Value by Region (2024-2034)
3.3.3 Global Short Bowel Syndrome (SBS) Drugs Sales (Volume & Value), Price and Gross Margin (2024-2034)
4 Global Short Bowel Syndrome (SBS) Drugs by Sale Channel
4.1 Short Bowel Syndrome (SBS) Drugs Market Segment by Sale Channel
4.1.1 Hospitals
4.1.2 Clinics
4.1.3 Retail Pharmacies
4.2 Global Short Bowel Syndrome (SBS) Drugs Market Size by Sale Channel
4.2.1 Global Short Bowel Syndrome (SBS) Drugs Market Size Overview by Sale Channel (2018-2034)
4.2.2 Global Short Bowel Syndrome (SBS) Drugs Historic Market Size Review by Sale Channel (2018-2024)
4.2.3 Global Short Bowel Syndrome (SBS) Drugs Forecasted Market Size by Sale Channel (2024-2034)
4.3 Key Regions Market Size Segment by Sale Channel
4.3.1 North America Short Bowel Syndrome (SBS) Drugs Sales Breakdown by Sale Channel (2018-2024)
4.3.2 Europe Short Bowel Syndrome (SBS) Drugs Sales Breakdown by Sale Channel (2018-2024)
4.3.3 Asia-Pacific Short Bowel Syndrome (SBS) Drugs Sales Breakdown by Sale Channel (2018-2024)
4.3.4 Latin America Short Bowel Syndrome (SBS) Drugs Sales Breakdown by Sale Channel (2018-2024)
4.3.5 Middle East and Africa Short Bowel Syndrome (SBS) Drugs Sales Breakdown by Sale Channel (2018-2024)
5 North America Short Bowel Syndrome (SBS) Drugs by Country
5.1 North America Short Bowel Syndrome (SBS) Drugs Historic Market Size by Country
5.1.1 North America Short Bowel Syndrome (SBS) Drugs Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
5.1.2 North America Short Bowel Syndrome (SBS) Drugs Sales in Volume by Country (2018-2024)
5.1.3 North America Short Bowel Syndrome (SBS) Drugs Sales in Value by Country (2018-2024)
5.2 North America Short Bowel Syndrome (SBS) Drugs Forecasted Market Size by Country
5.2.1 North America Short Bowel Syndrome (SBS) Drugs Sales in Volume by Country (2024-2034)
5.2.2 North America Short Bowel Syndrome (SBS) Drugs Sales in Value by Country (2024-2034)
6 Europe Short Bowel Syndrome (SBS) Drugs by Country
6.1 Europe Short Bowel Syndrome (SBS) Drugs Historic Market Size by Country
6.1.1 Europe Short Bowel Syndrome (SBS) Drugs Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
6.1.2 Europe Short Bowel Syndrome (SBS) Drugs Sales in Volume by Country (2018-2024)
6.1.3 Europe Short Bowel Syndrome (SBS) Drugs Sales in Value by Country (2018-2024)
6.2 Europe Short Bowel Syndrome (SBS) Drugs Forecasted Market Size by Country
6.2.1 Europe Short Bowel Syndrome (SBS) Drugs Sales in Volume by Country (2024-2034)
6.2.2 Europe Short Bowel Syndrome (SBS) Drugs Sales in Value by Country (2024-2034)
7 Asia-Pacific Short Bowel Syndrome (SBS) Drugs by Region
7.1 Asia-Pacific Short Bowel Syndrome (SBS) Drugs Historic Market Size by Region
7.1.1 Asia-Pacific Short Bowel Syndrome (SBS) Drugs Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2034
7.1.2 Asia-Pacific Short Bowel Syndrome (SBS) Drugs Sales in Volume by Region (2018-2024)
7.1.3 Asia-Pacific Short Bowel Syndrome (SBS) Drugs Sales in Value by Region (2018-2024)
7.2 Asia-Pacific Short Bowel Syndrome (SBS) Drugs Forecasted Market Size by Region
7.2.1 Asia-Pacific Short Bowel Syndrome (SBS) Drugs Sales in Volume by Region (2024-2034)
7.2.2 Asia-Pacific Short Bowel Syndrome (SBS) Drugs Sales in Value by Region (2024-2034)
8 Latin America Short Bowel Syndrome (SBS) Drugs by Country
8.1 Latin America Short Bowel Syndrome (SBS) Drugs Historic Market Size by Country
8.1.1 Latin America Short Bowel Syndrome (SBS) Drugs Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
8.1.2 Latin America Short Bowel Syndrome (SBS) Drugs Sales in Volume by Country (2018-2024)
8.1.3 Latin America Short Bowel Syndrome (SBS) Drugs Sales in Value by Country (2018-2024)
8.2 Latin America Short Bowel Syndrome (SBS) Drugs Forecasted Market Size by Country
8.2.1 Latin America Short Bowel Syndrome (SBS) Drugs Sales in Volume by Country (2024-2034)
8.2.2 Latin America Short Bowel Syndrome (SBS) Drugs Sales in Value by Country (2024-2034)
9 Middle East and Africa Short Bowel Syndrome (SBS) Drugs by Country
9.1 Middle East and Africa Short Bowel Syndrome (SBS) Drugs Historic Market Size by Country
9.1.1 Middle East and Africa Short Bowel Syndrome (SBS) Drugs Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
9.1.2 Middle East and Africa Short Bowel Syndrome (SBS) Drugs Sales in Volume by Country (2018-2024)
9.1.3 Middle East and Africa Short Bowel Syndrome (SBS) Drugs Sales in Value by Country (2018-2024)
9.2 Middle East and Africa Short Bowel Syndrome (SBS) Drugs Forecasted Market Size by Country
9.2.1 Middle East and Africa Short Bowel Syndrome (SBS) Drugs Sales in Volume by Country (2024-2034)
9.2.2 Middle East and Africa Short Bowel Syndrome (SBS) Drugs Sales in Value by Country (2024-2034)
10 Company Profiles
10.1 Merck
10.1.1 Merck Company Information
10.1.2 Merck Introduction and Business Overview
10.1.3 Merck Short Bowel Syndrome (SBS) Drugs Sales, Revenue and Gross Margin (2018-2024)
10.1.4 Merck Short Bowel Syndrome (SBS) Drugs Products Offered
10.1.5 Merck Recent Development
10.2 Takeda
10.2.1 Takeda Company Information
10.2.2 Takeda Introduction and Business Overview
10.2.3 Takeda Short Bowel Syndrome (SBS) Drugs Sales, Revenue and Gross Margin (2018-2024)
10.2.4 Takeda Short Bowel Syndrome (SBS) Drugs Products Offered
10.2.5 Takeda Recent Development
10.3 Emmaus Medical
10.3.1 Emmaus Medical Company Information
10.3.2 Emmaus Medical Introduction and Business Overview
10.3.3 Emmaus Medical Short Bowel Syndrome (SBS) Drugs Sales, Revenue and Gross Margin (2018-2024)
10.3.4 Emmaus Medical Short Bowel Syndrome (SBS) Drugs Products Offered
10.3.5 Emmaus Medical Recent Development
10.4 Ardelyx
10.4.1 Ardelyx Company Information
10.4.2 Ardelyx Introduction and Business Overview
10.4.3 Ardelyx Short Bowel Syndrome (SBS) Drugs Sales, Revenue and Gross Margin (2018-2024)
10.4.4 Ardelyx Short Bowel Syndrome (SBS) Drugs Products Offered
10.4.5 Ardelyx Recent Development
10.5 Naia Pharmaceuticals
10.5.1 Naia Pharmaceuticals Company Information
10.5.2 Naia Pharmaceuticals Introduction and Business Overview
10.5.3 Naia Pharmaceuticals Short Bowel Syndrome (SBS) Drugs Sales, Revenue and Gross Margin (2018-2024)
10.5.4 Naia Pharmaceuticals Short Bowel Syndrome (SBS) Drugs Products Offered
10.5.5 Naia Pharmaceuticals Recent Development
10.6 Nutrinia
10.6.1 Nutrinia Company Information
10.6.2 Nutrinia Introduction and Business Overview
10.6.3 Nutrinia Short Bowel Syndrome (SBS) Drugs Sales, Revenue and Gross Margin (2018-2024)
10.6.4 Nutrinia Short Bowel Syndrome (SBS) Drugs Products Offered
10.6.5 Nutrinia Recent Development
10.7 OxThera
10.7.1 OxThera Company Information
10.7.2 OxThera Introduction and Business Overview
10.7.3 OxThera Short Bowel Syndrome (SBS) Drugs Sales, Revenue and Gross Margin (2018-2024)
10.7.4 OxThera Short Bowel Syndrome (SBS) Drugs Products Offered
10.7.5 OxThera Recent Development
10.8 Sancilio Pharmaceuticals
10.8.1 Sancilio Pharmaceuticals Company Information
10.8.2 Sancilio Pharmaceuticals Introduction and Business Overview
10.8.3 Sancilio Pharmaceuticals Short Bowel Syndrome (SBS) Drugs Sales, Revenue and Gross Margin (2018-2024)
10.8.4 Sancilio Pharmaceuticals Short Bowel Syndrome (SBS) Drugs Products Offered
10.8.5 Sancilio Pharmaceuticals Recent Development
10.9 Zealand Pharma
10.9.1 Zealand Pharma Company Information
10.9.2 Zealand Pharma Introduction and Business Overview
10.9.3 Zealand Pharma Short Bowel Syndrome (SBS) Drugs Sales, Revenue and Gross Margin (2018-2024)
10.9.4 Zealand Pharma Short Bowel Syndrome (SBS) Drugs Products Offered
10.9.5 Zealand Pharma Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Short Bowel Syndrome (SBS) Drugs Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Short Bowel Syndrome (SBS) Drugs Industrial Chain Analysis
11.4 Short Bowel Syndrome (SBS) Drugs Market Dynamics
11.4.1 Short Bowel Syndrome (SBS) Drugs Industry Trends
11.4.2 Short Bowel Syndrome (SBS) Drugs Market Drivers
11.4.3 Short Bowel Syndrome (SBS) Drugs Market Challenges
11.4.4 Short Bowel Syndrome (SBS) Drugs Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Short Bowel Syndrome (SBS) Drugs Distributors
12.3 Short Bowel Syndrome (SBS) Drugs Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer

List of Figure

List of Tables
Table 1. Major Company of Glucagon-Like Peptide-2 (GLP-2)
Table 2. Major Company of Growth Hormone
Table 3. Major Company of Glutamine
Table 4. Major Company of Other
Table 5. Global Short Bowel Syndrome (SBS) Drugs Sales by Type 2018 VS 2022 VS 2034 (US$ Million)
Table 6. Global Short Bowel Syndrome (SBS) Drugs Sales by Type (2018-2024) & (K Pcs)
Table 7. Global Short Bowel Syndrome (SBS) Drugs Sales Market Share in Volume by Type (2018-2024)
Table 8. Global Short Bowel Syndrome (SBS) Drugs Sales by Type (2018-2024) & (US& Million)
Table 9. Global Short Bowel Syndrome (SBS) Drugs Market Share in Value by Type (2018-2024)
Table 10. Global Short Bowel Syndrome (SBS) Drugs Price by Type (2018-2024) & (USD/Pcs)
Table 11. Global Short Bowel Syndrome (SBS) Drugs Sales by Type (2024-2034) & (K Pcs)
Table 12. Global Short Bowel Syndrome (SBS) Drugs Sales Market Share in Volume by Type (2024-2034)
Table 13. Global Short Bowel Syndrome (SBS) Drugs Sales by Type (2024-2034) & (US$ Million)
Table 14. Global Short Bowel Syndrome (SBS) Drugs Sales Market Share in Value by Type (2024-2034)
Table 15. Global Short Bowel Syndrome (SBS) Drugs Price by Type (2024-2034) & (USD/Pcs)
Table 16. North America Short Bowel Syndrome (SBS) Drugs Sales by Type (2018-2024) & (K Pcs)
Table 17. North America Short Bowel Syndrome (SBS) Drugs Sales by Type (2018-2024) & (US$ Million)
Table 18. Europe Short Bowel Syndrome (SBS) Drugs Sales (K Pcs) by Type (2018-2024)
Table 19. Europe Short Bowel Syndrome (SBS) Drugs Sales by Type (2018-2024) & (US$ Million)
Table 20. Asia-Pacific Short Bowel Syndrome (SBS) Drugs Sales (K Pcs) by Type (2018-2024)
Table 21. Asia-Pacific Short Bowel Syndrome (SBS) Drugs Sales by Type (2018-2024) & (US$ Million)
Table 22. Latin America Short Bowel Syndrome (SBS) Drugs Sales (K Pcs) by Type (2018-2024)
Table 23. Latin America Short Bowel Syndrome (SBS) Drugs Sales by Type (2018-2024) & (US$ Million)
Table 24. Middle East and Africa Short Bowel Syndrome (SBS) Drugs Sales (K Pcs) by Type (2018-2024)
Table 25. Middle East and Africa Short Bowel Syndrome (SBS) Drugs Sales by Type (2018-2024) & (US$ Million)
Table 26. Global Short Bowel Syndrome (SBS) Drugs Sales by Company (2018-2024) & (K Pcs)
Table 27. Global Short Bowel Syndrome (SBS) Drugs Sales Share by Company (2018-2024)
Table 28. Global Short Bowel Syndrome (SBS) Drugs Revenue by Company (2018-2024) & (US$ Million)
Table 29. Global Short Bowel Syndrome (SBS) Drugs Revenue Share by Company (2018-2024)
Table 30. Global Market Short Bowel Syndrome (SBS) Drugs Price by Company (2018-2024) & (USD/Pcs)
Table 31. Global Short Bowel Syndrome (SBS) Drugs Top Manufacturers Manufacturing Base Distribution and Sales Area
Table 32. Global Short Bowel Syndrome (SBS) Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 33. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Short Bowel Syndrome (SBS) Drugs as of 2022)
Table 34. Date of Key Manufacturers Enter into Short Bowel Syndrome (SBS) Drugs Market
Table 35. Key Manufacturers Short Bowel Syndrome (SBS) Drugs Product Type
Table 36. Mergers & Acquisitions, Expansion Plans
Table 37. Global Short Bowel Syndrome (SBS) Drugs Market Size Comparison by Region (US$ Million): 2018 VS 2022 VS 2034
Table 38. Global Short Bowel Syndrome (SBS) Drugs Sales by Region (2018-2024) & (K Pcs)
Table 39. Global Short Bowel Syndrome (SBS) Drugs Sales Market Share in Volume by Region (2018-2024)
Table 40. Global Short Bowel Syndrome (SBS) Drugs Sales by Region (2018-2024) & (US$ Million)
Table 41. Global Short Bowel Syndrome (SBS) Drugs Sales Market Share in Value by Region (2018-2024)
Table 42. Global Short Bowel Syndrome (SBS) Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 43. Global Short Bowel Syndrome (SBS) Drugs Sales by Region (2024-2034) & (K Pcs)
Table 44. Global Short Bowel Syndrome (SBS) Drugs Sales Market Share in Volume by Region (2024-2034)
Table 45. Global Short Bowel Syndrome (SBS) Drugs Sales by Region (2024-2034) & (US$ Million)
Table 46. Global Short Bowel Syndrome (SBS) Drugs Sales Market Share in Value by Region (2024-2034)
Table 47. Global Short Bowel Syndrome (SBS) Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2024-2034)
Table 48. Global Short Bowel Syndrome (SBS) Drugs Sales by Sale Channel: 2018 VS 2022 VS 2034 (US$ Million)
Table 49. Global Short Bowel Syndrome (SBS) Drugs Sales by Sale Channel (2018-2024) & (K Pcs)
Table 50. Global Short Bowel Syndrome (SBS) Drugs Sales Market Share in Volume by Sale Channel (2018-2024)
Table 51. Global Short Bowel Syndrome (SBS) Drugs Sales by Sale Channel (2018-2024) & (US$ Million)
Table 52. Global Short Bowel Syndrome (SBS) Drugs Sales Market Share in Value by Sale Channel (2018-2024)
Table 53. Global Short Bowel Syndrome (SBS) Drugs Price by Sale Channel (2018-2024) & (USD/Pcs)
Table 54. Global Short Bowel Syndrome (SBS) Drugs Sales by Sale Channel (2024-2034) & (K Pcs)
Table 55. Global Short Bowel Syndrome (SBS) Drugs Sales Market Share in Volume by Sale Channel (2024-2034)
Table 56. Global Short Bowel Syndrome (SBS) Drugs Sales by Sale Channel (2024-2034) & (US$ Million)
Table 57. Global Short Bowel Syndrome (SBS) Drugs Sales Market Share in Value by Sale Channel (2024-2034)
Table 58. Global Short Bowel Syndrome (SBS) Drugs Price by Sale Channel (2024-2034) & (USD/Pcs)
Table 59. North America Short Bowel Syndrome (SBS) Drugs Sales by Sale Channel (2018-2024) (K Pcs)
Table 60. North America Short Bowel Syndrome (SBS) Drugs Sales by Sale Channel (2018-2024) & (US$ Million)
Table 61. Europe Short Bowel Syndrome (SBS) Drugs Sales by Sale Channel (2018-2024) (K Pcs)
Table 62. Europe Short Bowel Syndrome (SBS) Drugs Sales by Sale Channel (2018-2024) & (US$ Million)
Table 63. Asia-Pacific Short Bowel Syndrome (SBS) Drugs Sales by Sale Channel (2018-2024) (K Pcs)
Table 64. Asia-Pacific Short Bowel Syndrome (SBS) Drugs Sales by Sale Channel (2018-2024) & (US$ Million)
Table 65. Latin America Short Bowel Syndrome (SBS) Drugs Sales by Sale Channel (2018-2024) (K Pcs)
Table 66. Latin America Short Bowel Syndrome (SBS) Drugs Sales by Sale Channel (2018-2024) & (US$ Million)
Table 67. Middle East and Africa Short Bowel Syndrome (SBS) Drugs Sales by Sale Channel (2018-2024) (K Pcs)
Table 68. Middle East and Africa Short Bowel Syndrome (SBS) Drugs Sales by Sale Channel (2018-2024) & (US$ Million)
Table 69. North America Short Bowel Syndrome (SBS) Drugs Sales by Country (2018-2024) & (K Pcs)
Table 70. North America Short Bowel Syndrome (SBS) Drugs Sales Market Share in Volume by Country (2018-2024)
Table 71. North America Short Bowel Syndrome (SBS) Drugs Sales by Country (2018-2024) & (US$ Million)
Table 72. North America Short Bowel Syndrome (SBS) Drugs Sales Market Share in Value by Country (2018-2024)
Table 73. North America Short Bowel Syndrome (SBS) Drugs Sales by Country (2024-2034) & (K Pcs)
Table 74. North America Short Bowel Syndrome (SBS) Drugs Sales Market Share in Volume by Country (2024-2034)
Table 75. North America Short Bowel Syndrome (SBS) Drugs Sales by Country (2024-2034) & (US$ Million)
Table 76. North America Short Bowel Syndrome (SBS) Drugs Sales Market Share in Value by Country (2024-2034)
Table 77. Europe Short Bowel Syndrome (SBS) Drugs Sales by Country (2018-2024) & (K Pcs)
Table 78. Europe Short Bowel Syndrome (SBS) Drugs Sales Market Share in Volume by Country (2018-2024)
Table 79. Europe Short Bowel Syndrome (SBS) Drugs Sales by Country (2018-2024) & (US$ Million)
Table 80. Europe Short Bowel Syndrome (SBS) Drugs Sales Market Share in Value by Country (2018-2024)
Table 81. Europe Short Bowel Syndrome (SBS) Drugs Sales by Country (2024-2034) & (K Pcs)
Table 82. Europe Short Bowel Syndrome (SBS) Drugs Sales Market Share in Volume by Country (2024-2034)
Table 83. Europe Short Bowel Syndrome (SBS) Drugs Sales by Country (2024-2034) & (US$ Million)
Table 84. Europe Short Bowel Syndrome (SBS) Drugs Sales Market Share in Value by Country (2024-2034)
Table 85. Asia-Pacific Short Bowel Syndrome (SBS) Drugs Sales by Region (2018-2024) & (K Pcs)
Table 86. Asia-Pacific Short Bowel Syndrome (SBS) Drugs Sales Market Share in Volume by Region (2018-2024)
Table 87. Asia-Pacific Short Bowel Syndrome (SBS) Drugs Sales by Region (2018-2024) & (US$ Million)
Table 88. Asia-Pacific Short Bowel Syndrome (SBS) Drugs Sales Market Share in Value by Region (2018-2024)
Table 89. Asia-Pacific Short Bowel Syndrome (SBS) Drugs Sales by Region (2024-2034) & (K Pcs)
Table 90. Asia-Pacific Short Bowel Syndrome (SBS) Drugs Sales Market Share in Volume by Region (2024-2034)
Table 91. Asia-Pacific Short Bowel Syndrome (SBS) Drugs Sales by Region (2024-2034) & (US$ Million)
Table 92. Asia-Pacific Short Bowel Syndrome (SBS) Drugs Sales Market Share in Value by Region (2024-2034)
Table 93. Latin America Short Bowel Syndrome (SBS) Drugs Sales by Country (2018-2024) & (K Pcs)
Table 94. Latin America Short Bowel Syndrome (SBS) Drugs Sales Market Share in Volume by Country (2018-2024)
Table 95. Latin America Short Bowel Syndrome (SBS) Drugs Sales by Country (2018-2024) & (US$ Million)
Table 96. Latin America Short Bowel Syndrome (SBS) Drugs Sales Market Share in Value by Country (2018-2024)
Table 97. Latin America Short Bowel Syndrome (SBS) Drugs Sales by Country (2024-2034) & (K Pcs)
Table 98. Latin America Short Bowel Syndrome (SBS) Drugs Sales Market Share in Volume by Country (2024-2034)
Table 99. Latin America Short Bowel Syndrome (SBS) Drugs Sales by Country (2024-2034) & (US$ Million)
Table 100. Latin America Short Bowel Syndrome (SBS) Drugs Sales Market Share in Value by Country (2024-2034)
Table 101. Middle East and Africa Short Bowel Syndrome (SBS) Drugs Sales by Country (2018-2024) & (K Pcs)
Table 102. Middle East and Africa Short Bowel Syndrome (SBS) Drugs Sales Market Share in Volume by Country (2018-2024)
Table 103. Middle East and Africa Short Bowel Syndrome (SBS) Drugs Sales by Country (2018-2024) & (US$ Million)
Table 104. Middle East and Africa Short Bowel Syndrome (SBS) Drugs Sales Market Share in Value by Country (2018-2024)
Table 105. Middle East and Africa Short Bowel Syndrome (SBS) Drugs Sales by Country (2024-2034) & (K Pcs)
Table 106. Middle East and Africa Short Bowel Syndrome (SBS) Drugs Sales Market Share in Volume by Country (2024-2034)
Table 107. Middle East and Africa Short Bowel Syndrome (SBS) Drugs Sales by Country (2024-2034) & (US$ Million)
Table 108. Middle East and Africa Short Bowel Syndrome (SBS) Drugs Sales Market Share in Value by Country (2024-2034)
Table 109. Merck Company Information
Table 110. Merck Introduction and Business Overview
Table 111. Merck Short Bowel Syndrome (SBS) Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 112. Merck Short Bowel Syndrome (SBS) Drugs Product
Table 113. Merck Recent Development
Table 114. Takeda Company Information
Table 115. Takeda Introduction and Business Overview
Table 116. Takeda Short Bowel Syndrome (SBS) Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 117. Takeda Short Bowel Syndrome (SBS) Drugs Product
Table 118. Takeda Recent Development
Table 119. Emmaus Medical Company Information
Table 120. Emmaus Medical Introduction and Business Overview
Table 121. Emmaus Medical Short Bowel Syndrome (SBS) Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 122. Emmaus Medical Short Bowel Syndrome (SBS) Drugs Product
Table 123. Emmaus Medical Recent Development
Table 124. Ardelyx Company Information
Table 125. Ardelyx Introduction and Business Overview
Table 126. Ardelyx Short Bowel Syndrome (SBS) Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 127. Ardelyx Short Bowel Syndrome (SBS) Drugs Product
Table 128. Ardelyx Recent Development
Table 129. Naia Pharmaceuticals Company Information
Table 130. Naia Pharmaceuticals Introduction and Business Overview
Table 131. Naia Pharmaceuticals Short Bowel Syndrome (SBS) Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 132. Naia Pharmaceuticals Short Bowel Syndrome (SBS) Drugs Product
Table 133. Naia Pharmaceuticals Recent Development
Table 134. Nutrinia Company Information
Table 135. Nutrinia Introduction and Business Overview
Table 136. Nutrinia Short Bowel Syndrome (SBS) Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 137. Nutrinia Short Bowel Syndrome (SBS) Drugs Product
Table 138. Nutrinia Recent Development
Table 139. OxThera Company Information
Table 140. OxThera Introduction and Business Overview
Table 141. OxThera Short Bowel Syndrome (SBS) Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 142. OxThera Short Bowel Syndrome (SBS) Drugs Product
Table 143. OxThera Recent Development
Table 144. Sancilio Pharmaceuticals Company Information
Table 145. Sancilio Pharmaceuticals Introduction and Business Overview
Table 146. Sancilio Pharmaceuticals Short Bowel Syndrome (SBS) Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 147. Sancilio Pharmaceuticals Short Bowel Syndrome (SBS) Drugs Product
Table 148. Sancilio Pharmaceuticals Recent Development
Table 149. Zealand Pharma Company Information
Table 150. Zealand Pharma Introduction and Business Overview
Table 151. Zealand Pharma Short Bowel Syndrome (SBS) Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 152. Zealand Pharma Short Bowel Syndrome (SBS) Drugs Product
Table 153. Zealand Pharma Recent Development
Table 154. Key Raw Materials Lists
Table 155. Raw Materials Key Suppliers Lists
Table 156. Short Bowel Syndrome (SBS) Drugs Market Trends
Table 157. Short Bowel Syndrome (SBS) Drugs Market Drivers
Table 158. Short Bowel Syndrome (SBS) Drugs Market Challenges
Table 159. Short Bowel Syndrome (SBS) Drugs Market Restraints
Table 160. Short Bowel Syndrome (SBS) Drugs Distributors List
Table 161. Short Bowel Syndrome (SBS) Drugs Downstream Customers
Table 162. Research Programs/Design for This Report
Table 163. Key Data Information from Secondary Sources
Table 164. Key Data Information from Primary Sources
List of Figures
Figure 1. Short Bowel Syndrome (SBS) Drugs Product Picture
Figure 2. Global Short Bowel Syndrome (SBS) Drugs Market Size, 2018 VS 2022 VS 2034 (US$ Million)
Figure 3. Global Short Bowel Syndrome (SBS) Drugs Market Size Status and Outlook (2018-2034) & (US$ Million)
Figure 4. Global Short Bowel Syndrome (SBS) Drugs Sales Status and Outlook (2018-2034) & (K Pcs)
Figure 5. Product Picture of Glucagon-Like Peptide-2 (GLP-2)
Figure 6. Global Glucagon-Like Peptide-2 (GLP-2) Sales YoY Growth (2018-2034) & (K Pcs)
Figure 7. Product Picture of Growth Hormone
Figure 8. Global Growth Hormone Sales YoY Growth (2018-2034) & (K Pcs)
Figure 9. Product Picture of Glutamine
Figure 10. Global Glutamine Sales YoY Growth (2018-2034) & (K Pcs)
Figure 11. Product Picture of Other
Figure 12. Global Other Sales YoY Growth (2018-2034) & (K Pcs)
Figure 13. Global Short Bowel Syndrome (SBS) Drugs Sales by Type (2018-2034) & (US$ Million)
Figure 14. Global Short Bowel Syndrome (SBS) Drugs Sales Market Share by Type in 2022 & 2034
Figure 15. North America Short Bowel Syndrome (SBS) Drugs Sales Market Share in Volume by Type in 2022
Figure 16. North America Short Bowel Syndrome (SBS) Drugs Sales Market Share in Value by Type in 2022
Figure 17. Europe Short Bowel Syndrome (SBS) Drugs Sales Market Share in Volume by Type in 2022
Figure 18. Europe Short Bowel Syndrome (SBS) Drugs Sales Market Share in Value by Type in 2022
Figure 19. Asia-Pacific Short Bowel Syndrome (SBS) Drugs Sales Market Share in Volume by Type in 2022
Figure 20. Asia-Pacific Short Bowel Syndrome (SBS) Drugs Sales Market Share in Value by Type in 2022
Figure 21. Latin America Short Bowel Syndrome (SBS) Drugs Sales Market Share in Volume by Type in 2022
Figure 22. Latin America Short Bowel Syndrome (SBS) Drugs Sales Market Share in Value by Type in 2022
Figure 23. Middle East and Africa Short Bowel Syndrome (SBS) Drugs Sales Market Share in Volume by Type in 2022
Figure 24. Middle East and Africa Short Bowel Syndrome (SBS) Drugs Sales Market Share in Value by Type in 2022
Figure 25. The 5 and 10 Largest Manufacturers in the World: Market Share by Short Bowel Syndrome (SBS) Drugs Sales in 2022
Figure 26. The 5 and 10 Largest Manufacturers in the World: Market Share by Short Bowel Syndrome (SBS) Drugs Revenue in 2022
Figure 27. Short Bowel Syndrome (SBS) Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 28. Product Picture of Hospitals
Figure 29. Global Hospitals Sales YoY Growth (2018-2034) & (K Pcs)
Figure 30. Product Picture of Clinics
Figure 31. Global Clinics Sales YoY Growth (2018-2034) & (K Pcs)
Figure 32. Product Picture of Retail Pharmacies
Figure 33. Global Retail Pharmacies Sales YoY Growth (2018-2034) & (K Pcs)
Figure 34. Global Short Bowel Syndrome (SBS) Drugs Sales by Sale Channel (2018-2034) & (US$ Million)
Figure 35. Global Short Bowel Syndrome (SBS) Drugs Sales Market Share by Sale Channel in 2022 & 2034
Figure 36. North America Short Bowel Syndrome (SBS) Drugs Sales Market Share in Volume by Sale Channel in 2022
Figure 37. North America Short Bowel Syndrome (SBS) Drugs Sales Market Share in Value by Sale Channel in 2022
Figure 38. Europe Short Bowel Syndrome (SBS) Drugs Sales Market Share in Volume by Sale Channel in 2022
Figure 39. Europe Short Bowel Syndrome (SBS) Drugs Sales Market Share in Value by Sale Channel in 2022
Figure 40. Asia-Pacific Short Bowel Syndrome (SBS) Drugs Sales Market Share in Volume by Sale Channel in 2022
Figure 41. Asia-Pacific Short Bowel Syndrome (SBS) Drugs Sales Market Share in Value by Sale Channel in 2022
Figure 42. Latin America Short Bowel Syndrome (SBS) Drugs Sales Market Share in Volume by Sale Channel in 2022
Figure 43. Latin America Short Bowel Syndrome (SBS) Drugs Sales Market Share in Value by Sale Channel in 2022
Figure 44. Middle East and Africa Short Bowel Syndrome (SBS) Drugs Sales Market Share in Value by Sale Channel in 2022
Figure 45. Key Raw Materials Price
Figure 46. Short Bowel Syndrome (SBS) Drugs Manufacturing Cost Structure
Figure 47. Short Bowel Syndrome (SBS) Drugs Industrial Chain Analysis
Figure 48. Channels of Distribution
Figure 49. Distributors Profiles
Figure 50. Bottom-up and Top-down Approaches for This Report
Figure 51. Data Triangulation
Figure 52. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries